Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women

NCT00165698 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: menatetranone
DRUG: alfacalcidol

Sponsor

Eisai Co., Ltd.